Aaron Eggebeen, MD
Basic profileAaron Eggebeen is a Rheumatology/Immunology physician affiliated with Calvin University. OpenAlex indexes 6 publications with 784 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cardinal Health 110 LLCProgram year20211 payment$100
- Janssen Biotech, Inc.Program year20214 payments$55
- Genentech USA, Inc.Program year20211 payment$50
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
59.2%TNF inhibitor39.6%Infliximab87%Enbrel Sureclick7%Humira(Cf) Pen4%Enbrel1%Cimzia1%Simponi1%Humira(Cf)0%Part D + Part B<11 patientsFolate Analog Metabolic Inhibitor10.9%Methotrexate96%Methotrexate Sodium4%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
18.6%Corticosteroid11.5%Prednisone100%Part D≥268 patientsAntidiarrheal microorganisms4.1%Folic Acid100%Part D≥87 patients+ 2 more classes in this area
Nervous system
7.9%Opioid Agonist2.4%Tramadol Hcl82%Tramadol Hcl-Acetaminophen18%Part D<11 patientsGabapentinoids2.3%Gabapentin59%Pregabalin41%Part D≥26 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
BMC Medical Informatics and Decision Making
2013 - Gout: an update.
PubMed
2007
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”